EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective

Virginia Boccardi iD, Francesca Mancinetti, Patrizia Mecocci iD

Antioxidants · 25.08.2025 · 14 (9) · 1044

DOI: 10.3390/antiox14091044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 25.08.2025. Verfasst von Virginia Boccardi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, 06120 Perugia, Italy. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases such as Alzheimer’s disease (AD) are closely linked to oxidative stress and advanced glycation end products (AGEs), two interrelated processes that exacerbate neuronal damage through mitochondrial dysfunction, protein aggregation, and chronic inflammation. This narrative review explores the metabolic interplay between reactive oxygen species (ROS) and AGEs, with a focus on the AGE-RAGE (receptor for advanced glycation end products) signaling axis as a driver of neurodegeneration. Evidence from preclinical and clinical studies highlights their combined role in disease progression and underscores potential therapeutic targets. Strategies including mitochondria-targeted antioxidants, AGE inhibitors, RAGE antagonists, and metabolic interventions are discussed, along with future directions for biomarker development and personalized treatments. This review integrates current molecular insights into a unified metabolic–inflammatory model of AD, highlighting translational therapeutic opportunities.

Schlagwörter

Stichwörter der Autor:innen

aginginflammationinsulinmetabolismneurodegenerationoxidative stress

Autor:innen und Institutionen

  • Division of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, 06120 Perugia, Italy.
  • Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 17177 Stockholm, Sweden.

ORCID-Profile: Virginia Boccardi, Patrizia Mecocci

Zitieren

APA

Boccardi, V., Mancinetti, F., & Mecocci, P. (2025). Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective. Antioxidants, 14(9), 1044. https://doi.org/10.3390/antiox14091044

Vancouver

Boccardi V, Mancinetti F, Mecocci P. Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective. Antioxidants. 2025;14(9):1044. doi:10.3390/antiox14091044

BibTeX
@article{Boccardi2025,
  author = {Boccardi, Virginia and Mancinetti, Francesca and Mecocci, Patrizia},
  title = {Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {1044},
  doi = {10.3390/antiox14091044}
}
Kostenlos starten →